Supplements in the Ozempic Age and other trends redefining health

In this episode of The Natural List, co-hosts Jessica Rubino and Adrienne Smith welcome Nutrition Business Journal Editor in Chief Rick Polito for a candid discussion about the shifting supplement landscape. From the rise of GLP-1 drugs like Ozempic to the evolution of healthspan and longevity trends, this conversation cuts through the noise to ask: What’s hype, what’s helpful and what’s next? Rick shares insights from NBJ’s new report Supplements in the Ozempic Age, exploring how the weight loss drug boom is influencing consumer demand for ingredients like berberine, fiber and branded newcomers like Eriomin®. He breaks down how brands are either aligning with pharmaceuticals or offering natural alternatives—and what support consumers need before, during and after GLP-1 intervention. The discussion also touches on cognitive health, muscle maintenance, and the changing definition of longevity. With colostrum innovation, Irish sea moss and gut health in the mix, the episode offers a real-time look at which ingredients and ideas are capturing attention—and which ones might need a rethink. Tune in for honest opinions, industry insight and a lively debate on consumer education.